Innate Pharma announces first patient dosed in IPH6501 trial
PremiumThe FlyInnate Pharma announces first patient dosed in IPH6501 trial
7M ago
Innate Pharma announces Yannis Morel broadens remit to COO
Premium
The Fly
Innate Pharma announces Yannis Morel broadens remit to COO
9M ago
Innate Pharma announces FDA lifts clinical hold on lacutamab IND
Premium
The Fly
Innate Pharma announces FDA lifts clinical hold on lacutamab IND
9M ago
Innate Pharma reports encore presentation of TELLOMAK Phase 2 study results
PremiumThe FlyInnate Pharma reports encore presentation of TELLOMAK Phase 2 study results
12M ago
Innate Pharma price target lowered to $8 from $12 at Citi
Premium
The Fly
Innate Pharma price target lowered to $8 from $12 at Citi
1y ago
Innate Pharma doses first patient in Sanofi-sponsored SAR’514 / IPH6401 trial
Premium
The Fly
Innate Pharma doses first patient in Sanofi-sponsored SAR’514 / IPH6401 trial
1y ago
Innate Pharma announces $5M upfront payment from Takeda
PremiumThe FlyInnate Pharma announces $5M upfront payment from Takeda
1y ago
Innate Pharma enters exclusive license agreement with Takeda
Premium
The Fly
Innate Pharma enters exclusive license agreement with Takeda
1y ago
Innate Pharma provides update on SVB Financial exposure
Premium
The Fly
Innate Pharma provides update on SVB Financial exposure
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100